Search Results - "Veselovsky, E."

Lessons from the routine tumor molecular profiling in Russia by Mileyko, V., Rozhavskaya, E., Veselovsky, E., Kovtun, A., Ivanov, M., Ignatova, E.O.

Get full text

CRAC (Clinical Relevance of Alterations in Cancer): a Knowledge Base for the Selection of Molecularly Matched Therapy for Solid Tumors by Lebedeva, A A, Kavun, A I, Veselovsky, E M, Mileyko, V A, Ivanov, M V

“…Multigene testing using NGS (next-generation sequencing) provides a large amount of information and can detect multiple molecular alterations. Subsequent…”
Get full text

111P Leveraging in silico signatures to predict clinically actionable variants in oncogenes by Veselovsky, E., Yakushina, V., Lebedeva, A., Timokhin, G., Ivanov, M., Mileyko, V.

Get full text

96P Use of computational algorithms to predict mutation effect in clinical setting by Ignatova, E., Yakushina, V., Lebedeva, A., Timokhin, G., Veselovsky, E., Mileyko, V., Ivanov, M.

Get full text

101PClinical application of routine comprehensive tumour molecular profiling in the management of cancer patients by Mileyko, V, Veselovsky, E, Rozhavskaya, E, Ignatova, E, Kovtun, A, Sharova, M, Ivanov, M

“…Abstract Background Along with the extension of the FDA approved molecular matched therapies, the evidence is building to support molecular profile-based…”
Get full text

Clinical application of routine comprehensive tumour molecular profiling in the management of cancer patients by Mileyko, V., Veselovsky, E., Rozhavskaya, E., Ignatova, E., Kovtun, A., Sharova, M., Ivanov, M.

Get full text

45PLessons from the routine tumor molecular profiling in Russia by Mileyko, V, Rozhavskaya, E, Veselovsky, E, Kovtun, A, Ivanov, M, Ignatova, E O

Get full text

103P MSI detection by NGS using tumor samples and liquid biopsy for patients with solid tumors: A single institution experience by Lebedeva, A., Belova, E., Grigoreva, T., Kuznetsova, O.A., Kavun, A., Aliyarova, S., Veselovsky, E., Iudina, V., Nikulin, V., Kravchuk, D.A., Fedyanin, M., Mileyko, V., Ivanov, M.V.

Get full text

55P Impact of IHC/PCR discordance on immunotherapy (ICI) response in colorectal cancer (CRC) patients and prospects of liquid biopsy (LB) to replace conventional methods: Survival analysis of BLOOMSI trial by Lebedeva, A., Kuznetsova, O.A., Grigoreva, T., Taraskina, A., Kravchuk, D.A., Belova, E., Kavun, A., Ignatova, E., Veselovsky, E., Belyaeva, L., Nikulin, V., Sergeeva, A., Aliyarova, S., Mileyko, V., Tryakin, A., Fedyanin, M., Ivanov, M.

Get full text

67P Multi-institutional evaluation of interrater agreement of biomarker-drug pair rankings based on the ESMO scale for clinical actionability of molecular targets (ESCAT) and sources of discordance by Lebedeva, A., Taraskina, A., Belova, E., Kavun, A., Bartoletti, M., Bieche, I., Curigliano, G., Dupain, C., Kamal, M., Ignatova, E., Luchini, C., Poyarkov, S., Rios-Hoyo, A., Le Tourneau, C., Veselovsky, E., Mileyko, V., Ivanov, M.

Get full text

Polymorphism of the apolipoprotein E gene (APOE) in the populations of Russia and neighboring countries by Borinskaya, S. A., Kal’ina, N. R., Sanina, E. D., Kozhekbaeva, Zh. M., Gupalo, E. Yu, Garmash, I. V., Ogurtsov, P. P., Parshukova, O. N., Bojko, S. G., Veselovsky, E. M., Vershubskaya, G. G., Kozlov, A. I., Rogaev, E. I., Yankovsky, N. K.

Get full text